All UM showed increased sensitivity to the DNA-PK inhibitor NU7026 when compared with the control cell lines WM793, melanocyte progenitor cell line LA1-5s and a series of sarcoma cell lines (A673, SKUT-1, SKLMS-1 and SW1353, grouped to simplify the data) (Figure 3). Here, PRKDC is linked to sarcoma.